RCSB Protein Data Bank: Enabling biomedical research and drug discovery

David S. Goodsell,Christine Zardecki,Luigi Di Costanzo,Jose M. Duarte,Brian P. Hudson,Irina Persikova,Joan Segura,Chenghua Shao,Maria Voigt,John D. Westbrook,Jasmine Y. Young,Stephen K. Burley

DOI: https://doi.org/10.1002/pro.3730

IF: 8

2019-11-29

Protein Science

Abstract:<p>Analyses of publicly‐available structural data reveal interesting insights into the impact of the three‐dimensional (3D) structures of protein targets important for discovery of new drugs (e.g., G‐protein coupled receptors, voltage‐gated ion channels, ligand‐gated ion channels, transporters, and E3 ubiquitin ligases). The Protein Data Bank (PDB) archive currently holds &gt;155,000 atomic level 3D structures of biomolecules experimentally determined using crystallography, NMR spectroscopy, and electron microscopy. The PDB was established in 1971 as the first open‐access, digital‐data resource in biology, and is now managed by the Worldwide Protein Data Bank partnership (wwPDB; <a class="linkBehavior" href="http://www.wwpdb.org">wwPDB.org</a>). US PDB operations are the responsibility of the RCSB Protein Data Bank (RCSB PDB). The RCSB PDB serves millions of <a class="linkBehavior" href="http://rcsb.org">RCSB.org</a> users worldwide by delivering PDB data integrated with ~40 external biodata resources, providing rich structural views of fundamental biology, biomedicine, and energy sciences. Recently published work showed that the PDB archival holdings facilitated discovery of ~90% of the 210 new drugs approved by the US Food and Drug Administration (FDA) 2010–2016. We review user‐driven development of RCSB PDB services, examine growth of the PDB archive in terms of size and complexity, and present examples and opportunities for structure‐guided drug discovery for challenging targets (e.g., integral membrane proteins).</p><p>This article is protected by copyright. All rights reserved.</p>

biochemistry & molecular biology